Section of Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.
Hematol Oncol Clin North Am. 2011 Apr;25(2):335-58, viii. doi: 10.1016/j.hoc.2011.01.006.
Because von Willebrand factor (VWF) levels increase during pregnancy, many women with VWD, though not requiring support with hemostatic agents, are at increased risk for delayed postpartum hemorrhage as coagulation factor levels fall to their prepregnancy levels in the puerperium. Women with moderate or severe disease or complicated pregnancies are best served by delivering at a center with an obstetrician, hematologist, and anesthesiologist experienced in managing coagulation disorders. In addition, on-site laboratory facilities with specialized coagulation testing capability, pharmacy, and blood bank support are critical for success. Ensuring optimal outcomes for pregnant women with VWD requires a multidisciplinary approach.
由于妊娠期间 von Willebrand 因子(VWF)水平增加,许多患有 VWD 的女性尽管不需要止血剂支持,但由于凝血因子水平在产褥期降至孕前水平,她们有发生产后出血延迟的风险增加。患有中度或重度疾病或复杂妊娠的女性最好在具有产科医生、血液科医生和麻醉师经验的中心分娩,这些医生擅长管理凝血障碍。此外,拥有专门的凝血检测能力的现场实验室设施、药房和血库支持对于成功至关重要。确保患有 VWD 的孕妇获得最佳结局需要多学科方法。